FindTrial
Sign In

Benefit OF using two different type of drugs during operation.

A Comparative study of clinical effects and recovery characteristics of intraoperative dexmedetomidine infusion with ketamine vs fentanyl as adjuvant

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018028
Enrollment
80
Registered
2019-03-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Dexmedetomidine and ketamine infusion: Intraoperatively Intravenous Dexmedetomidine 0.5μg/kg/hr in combination with ketamine 0.5mg/kg/hr infusion will be given . Control Intervention1

Sponsors

Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ASA GRADE I-II Major Surgeries

Exclusion criteria

Exclusion criteria: 1-Lack of patients consent 2-ASA Grade III-IV 3-Renal and Hepatic dysfunction 4-Respiratory disorder

Design outcomes

Secondary

MeasureTime frame
Time for first analgesic requirements,duration of PACU stayTimepoint: 2 hourly in postoperative period for 6 hours.—

Primary

MeasureTime frame
Recovery time,hemodynamic vital.Timepoint: 10,20 min of induction,every 15 min throughout procedure—

Countries

India

Contacts

Public ContactMehershree

IMS,BHU,Varanasi

bhuapsingh@gmail.com9839412975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026